Alkermes (ALKS) Operating Expenses (2010 - 2026)
Alkermes (ALKS) reported Operating Expenses of $441.2 million for Q1 2026, up 50.72% year-over-year from $292.7 million in Q1 2025, and up 149.95% quarter-over-quarter from -$883.2 million in Q4 2025.
Alkermes (ALKS) Operating Expenses (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has 17 years of Operating Expenses data on file, last reported at $441.2 million in Q1 2026.
- Operating Expenses for Q1 2026 came in at $441.2 million, up 50.72% year-over-year; the trailing twelve-month figure through Mar 2026 was -$429.8 million (up 14.07% YoY), and the FY2025 annual result was $12.3 million, down 75.22% from the prior year.
- Operating Expenses advanced to $441.2 million in Q1 2026 per ALKS's latest filing, from -$883.2 million in the prior quarter.
- Over five years, Operating Expenses peaked at $441.2 million in Q1 2026 and troughed at -$883.2 million in Q4 2025.
- A 5-year average of $102.6 million and a median of $292.7 million in 2025 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2023 and 2024: Operating Expenses soared 70.74% in 2023, then slumped 354.02% in 2024.
- A 5-year view of Operating Expenses shows it stood at $189.1 million in 2022, then soared by 70.74% to $322.8 million in 2023, then tumbled by 354.02% to -$820.1 million in 2024, then dropped by 7.7% to -$883.2 million in 2025, then jumped by 149.95% to $441.2 million in 2026.
- Business Quant data shows ALKS's Operating Expenses at $441.2 million in Q1 2026, -$883.2 million in Q4 2025, and $6.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 526.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 788.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 455.70 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 19.40 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 621.10 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 478.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 441.19 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 475.11 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 96.91 Mn |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn | 71.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 441.19 Mn |
| Dec 31, 2025 | -883.21 Mn |
| Sep 30, 2025 | 6.32 Mn |
| Jun 30, 2025 | 5.88 Mn |
| Mar 31, 2025 | 292.72 Mn |
| Dec 31, 2024 | -820.10 Mn |
| Sep 30, 2024 | 11.98 Mn |
| Jun 30, 2024 | 15.24 Mn |
| Mar 31, 2024 | 307.06 Mn |
| Dec 31, 2023 | 322.84 Mn |
| Sep 30, 2023 | 291.74 Mn |
| Jun 30, 2023 | 336.13 Mn |
| Mar 31, 2023 | 298.57 Mn |
| Dec 31, 2022 | 189.08 Mn |
| Sep 30, 2022 | 313.00 Mn |
| Jun 30, 2022 | 310.68 Mn |
| Mar 31, 2022 | 305.13 Mn |
| Dec 31, 2021 | 195.05 Mn |
| Sep 30, 2021 | 313.80 Mn |
| Jun 30, 2021 | 299.30 Mn |